Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Konstantinos Anargyrou
Low Dose Melphalan Is a Treatment Option in Elderly Patients With High Risk Myelodysplastic Syndrome or Secondary Acute Myeloblastic Leukaemia
Haematologia
Related publications
A Phase II Study of AZD2171 (Cediranib) in the Treatment of Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology
Elderly Gastric Cancer Patients With Myelodysplastic Syndrome
Japanese Journal of Gastroenterological Surgery
Surgery
Gastroenterology
Effective Treatment of Low-Dose Decitabine in Myelodysplastic Syndrome/Myeloproliferative Neoplasms
OncoTargets and Therapy
Oncology
Pharmacology
Phase I Trial of SAR103168, a Novel Multi-Kinase Inhibitor, in Patients With Refractory/Relapsed Acute Leukemia or High-Risk Myelodysplastic Syndrome
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology
Clinical Efficacy of Chelation Therapy in Patients With Low-Risk Myelodysplastic Syndrome
Klinicheskaya Onkogematologiya/Clinical Oncohematology
Oncology
Hematology
Safety and Efficacy of Azacitidine in the Treatment of Elderly Patients With Myelodysplastic Syndrome
Clinical Interventions in Aging
Medicine
Gerontology
Geriatrics
Aplastic Anaemia, Acute Myeloblastic Leukaemia, and Oxymetholone
BMJ
Amiodarone Infusion in the Treatment of Acute Atrial Fibrillation or Flutter: High Versus Low Dose Treatment
Heart
Cardiovascular Medicine
Cardiology
8 Treatment of the Elderly Patient With Acute Myeloid Leukaemia
Baillière's Clinical Haematology
